“As he [Professor Simon Capewell, Vice President for Health Policy for the UK’s Faculty of Public Health] and I point out in an editorial published two weeks ago in medical journal BMC Medicine, community based studies reveal that almost 75 per cent of new users will stop taking their statin within a year of prescription with 62 per cent citing side effects as a reason,” writes Dr. Aseem Malhotra, a London-based cardiologist, in a recent article in The Daily Mail.
“In fact, the emerging evidence suggests at best, the benefits of statins have been grossly exaggerated and side effects underplayed.
“In recent weeks, two separate research groups in Japan and France have, independently of each other, questioned the reliability of many of the earlier industry sponsored studies that show the benefit of statins.
“In fact the Japanese research went as far to even suggests that statins may be a cause of the increasing population burden of heart failure.”
[See below for a list of articles which summarize what the Japanese research group and French and Swiss cardiologists concluded about statins.]
Dr. Malhotra is one of six doctors warning about the influence of drug companies on the prescribing of drugs.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.